These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 3826132)

  • 1. Progression of minimal-change glomerulopathy to focal glomerulosclerosis in a patient with fenoprofen nephropathy.
    Artinano M; Etheridge WB; Stroehlein KB; Barcenas CG
    Am J Nephrol; 1986; 6(5):353-7. PubMed ID: 3826132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fenoprofen-induced acute interstitial nephritis presenting with nephrotic syndrome.
    Lofgren RP; Nelson AE; Ehlers SM
    Minn Med; 1981 May; 64(5):287-90. PubMed ID: 7290034
    [No Abstract]   [Full Text] [Related]  

  • 3. Fenoprofen nephropathy: lipoid nephrosis and interstitial nephritis. A possible T-lymphocyte disorder.
    Finkelstein A; Fraley DS; Stachura I; Feldman HA; Gandy DR; Bourke E
    Am J Med; 1982 Jan; 72(1):81-7. PubMed ID: 6977270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The nephrotic syndrome caused by minimal lesions nephropathy and focal glomerulosclerosis. Morphological and clinical aspects].
    Barbiano Di Belgiojoso G; Bertoli S; Busnach G; Casanova S; Dal Col A; Confalonieri R; Galato R; Micoli G; Surian M; Minetti L
    Minerva Nefrol; 1981; 28(3):403-14. PubMed ID: 7329618
    [No Abstract]   [Full Text] [Related]  

  • 5. Renal failure associated with fenoprofen.
    Wendland ML; Wagoner RD; Holley KE
    Mayo Clin Proc; 1980 Feb; 55(2):103-7. PubMed ID: 7354644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glomerulonephritis Histopathological Pattern Change.
    AlYousef A; AlSahow A; AlHelal B; Alqallaf A; Abdallah E; Abdellatif M; Nawar H; Elmahalawy R
    BMC Nephrol; 2020 May; 21(1):186. PubMed ID: 32423387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T and B lymphocyte subsets in fenoprofen nephropathy.
    Stachura I; Jayakumar S; Bourke E
    Am J Med; 1983 Jul; 75(1):9-16. PubMed ID: 6602549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Reversible acute renal failure and nephrotic syndrome induced by fenoprofene ].
    Mourad G; Mimran A; Baldet P; Barjon P
    Nephrologie; 1982; 3(2):65-8. PubMed ID: 7121704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversible renal failure and nephrotic syndrome associated with nonsteroidal anti-inflammatory drugs.
    Brezin JH; Katz SM; Schwartz AB; Chinitz JL
    N Engl J Med; 1979 Dec; 301(23):1271-3. PubMed ID: 503131
    [No Abstract]   [Full Text] [Related]  

  • 10. [Histological classification of chronic glomerular diseases].
    Noël LH; Gubler MC
    Rev Prat; 2003 Nov; 53(18):2005-12. PubMed ID: 15008214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C1q nephropathy: a variant of focal segmental glomerulosclerosis.
    Markowitz GS; Schwimmer JA; Stokes MB; Nasr S; Seigle RL; Valeri AM; D'Agati VD
    Kidney Int; 2003 Oct; 64(4):1232-40. PubMed ID: 12969141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute tubular necrosis and minimal-change glomerulopathy associated with fenoprofen therapy.
    Dhar SK; Yum M
    Indiana Med; 1984 Dec; 77(12):956-7. PubMed ID: 6520381
    [No Abstract]   [Full Text] [Related]  

  • 13. Nonspecificity of the renal lesion of fenoprofen nephropathy.
    Bender WL; Whelton A; Beschorner WE; Darwish MO; Hall-Craggs M; Solez K
    Contrib Nephrol; 1984; 42():253-9. PubMed ID: 6335869
    [No Abstract]   [Full Text] [Related]  

  • 14. Reversible rapidly progressive renal failure with nephrotic syndrome due to fenoprofen calcium.
    Curt GA; Kaldany A; Whitley LG; Crosson AW; Rolla A; Merino MJ; D'Elia JA
    Ann Intern Med; 1980 Jan; 92(1):72-3. PubMed ID: 7350877
    [No Abstract]   [Full Text] [Related]  

  • 15. Patterns of renal involvement in a cohort of patients with inflammatory bowel disease in Egypt.
    Elaziz MMA; Fayed A
    Acta Gastroenterol Belg; 2018; 81(3):381-385. PubMed ID: 30350525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nephrotic syndrom with focal and segmental glomerulosclerosis in Dakar: epidemiological and clinicopathological characteristics (about 134 cases)].
    Niang A; Dial C; Ka EF; Lèye A; Pouye A; Ka MM; Mbengue M; Droz D; Diouf B
    Dakar Med; 2008; 53(1):45-51. PubMed ID: 19102117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgM-associated mesangial proliferative glomerulonephritis and focal and segmental hyalinosis with nephrotic syndrome.
    Aubert J; Humair L; Chatelanat F; de Torrenté A
    Am J Nephrol; 1985; 5(6):445-9. PubMed ID: 4083317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoid nephrosis and focal glomerulosclerosis.
    Childs WJ; Doak PB; Herdson PB
    Pathology; 1978 Apr; 10(2):113-29. PubMed ID: 355987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphological transition in minimal change nephrotic syndrome.
    Tejani A
    Nephron; 1985; 39(3):157-9. PubMed ID: 3974779
    [No Abstract]   [Full Text] [Related]  

  • 20. Correlation between relative interstitial volume of the renal cortex and serum creatinine concentration in minimal changes with nephrotic syndrome and in focal sclerosing glomerulonephritis.
    Bohle A; Glomb D; Grund KE; Mackensen S
    Virchows Arch A Pathol Anat Histol; 1977 Nov; 376(3):221-32. PubMed ID: 145718
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.